Evidence map›Paper›PMID 36070413›Full record

ArticleCell biochemistry and function2022

Evidence that cervical cancer cells cultured as tumorspheres maintain high CD73 expression and increase their protumor characteristics through TGF-β production.

Rosario García-Rocha, Alberto Monroy-García, Monserrat Carrera-Martínez, Jorge Hernández-Montes, Christian Azucena Don-López, Benny Weiss-Steider, Katia Alhelí Monroy-Mora, María de Los Ángeles Ponce-Chavero, Juan José Montesinos-Montesinos, María Luisa Escobar-Sánchez and 5 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Cell biochemistry and function, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Extracellular Adenosine in Gastric Cancer: The Role of GCSCs.International journal of molecular sciences · 2025
    Article
  3. Article
  4. Article
  5. Purinergic system in cancer stem cells.Purinergic signalling · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Rosario García-RochaLaboratorio de Inmunobiología, UIDCC-UMIEZ, FES-Zaragoza, UNAM, Ciudad de México, México.ORCID http://orcid.org/0000-0003-1789-4832
Alberto Monroy-GarcíaLaboratorio de Inmunobiología, UIDCC-UMIEZ, FES-Zaragoza, UNAM, Ciudad de México, México.ORCID http://orcid.org/0000-0002-9733-9013
Monserrat Carrera-MartínezLaboratorio de Inmunología y Cáncer, UIMEO, H Oncología, CMN SXXI, Instituto Mexicano del Seguro Social, Ciudad de México, México.
Jorge Hernández-MontesLaboratorio de Inmunobiología, UIDCC-UMIEZ, FES-Zaragoza, UNAM, Ciudad de México, México.ORCID http://orcid.org/0000-0003-0825-928X
Christian Azucena Don-LópezLaboratorio de Inmunobiología, UIDCC-UMIEZ, FES-Zaragoza, UNAM, Ciudad de México, México.ORCID http://orcid.org/0000-0001-5857-3440
Benny Weiss-SteiderLaboratorio de Inmunobiología, UIDCC-UMIEZ, FES-Zaragoza, UNAM, Ciudad de México, México.ORCID http://orcid.org/0000-0003-4893-530X
Katia Alhelí Monroy-MoraLaboratorio de Inmunobiología, UIDCC-UMIEZ, FES-Zaragoza, UNAM, Ciudad de México, México.
María de Los Ángeles Ponce-ChaveroLaboratorio de Inmunobiología, UIDCC-UMIEZ, FES-Zaragoza, UNAM, Ciudad de México, México.
Juan José Montesinos-MontesinosLaboratorio de Células Troncales Mesenquimales, Unidad de Investigación Médica en Enfermedades Oncológicas, CMN SXXI, Instituto Mexicano del Seguro Social, Ciudad de México, México.ORCID http://orcid.org/0000-0002-1042-3205
María Luisa Escobar-SánchezLaboratorio de Microscopía Electrónica, Departamento de Biología Celular, Facultad de Ciencias, Universidad Nacional Autónoma de México, Ciudad Universitaria, Ciudad de México, Mexico.
Gabriela Molina CastilloLaboratorio de Inmunobiología, UIDCC-UMIEZ, FES-Zaragoza, UNAM, Ciudad de México, México.ORCID http://orcid.org/0000-0001-5699-8920
Rommel Chacón-SalinasUnidad de Desarrollo e Investigación en Bioprocesos (UDIBI), Instituto Politécnico Nacional, Ciudad de México, Mexico.ORCID http://orcid.org/0000-0002-4500-0253
Luis Vallejo-CastilloUnidad de Desarrollo e Investigación en Bioprocesos (UDIBI), Instituto Politécnico Nacional, Ciudad de México, Mexico.ORCID http://orcid.org/0000-0002-9532-3472
Sonia Mayra Pérez-TapiaUnidad de Desarrollo e Investigación en Bioprocesos (UDIBI), Instituto Politécnico Nacional, Ciudad de México, Mexico.ORCID http://orcid.org/0000-0002-2818-8522
María de Lourdes Mora-GarcíaLaboratorio de Inmunobiología, UIDCC-UMIEZ, FES-Zaragoza, UNAM, Ciudad de México, México.ORCID http://orcid.org/0000-0001-7989-0162
Instituto Politécnico Nacional · MXMexican Social Security Institute · MXUniversidad Nacional Autónoma de México · MXUniversidad Autónoma de la Ciudad de México · MX

Funding

DGAPA-PAPIIT IN225519Instituto Mexicano del Seguro Social (IMSS) FIS/IMSS/PROT/PRIO/19/114 (R2018-3602-015)
6 · The paper itself

Abstract

Recently, a link between the biological activity of CD73 and tumorigenicity in solid tumors has been proposed. We previously reported that the generation of adenosine (Ado) by the activity of CD73 in cervical cancer (CC) cells induces transforming growth factor-beta 1 (TGF-β1) production to maintain CD73 expression. In the present study, we analyzed the participation of TGF-β1 in CD73 expression and the development of protumoral characteristics in CaSki CC cells cultured as tumorspheres (CaSki-T) and in monolayers (CaSki-M). Compared with those in CaSki-M cells, CD73 expression and Ado generation ability were significantly increased in CaSki-T cells. CaSki-T cells exhibited enrichment in the CSC-like phenotype due to increases in the expression levels of stem cell markers (CD49f, CK17, and P63; OCT4 and SOX2), greater sphere formation efficiency (SFE), and an increase in the percentage of side population (SP) cells. Interestingly, compared with CaSki-M cells, CaSki-T cells produced a greater amount of TGF-β1 and presented a marked protumor phenotype characterized by a significant decrease in the expression of major histocompatibility complex class-I (MHC-I) molecules, an increase in the expression of multidrug resistance protein-I (MRP-I) and vimentin, and an increase in the protein expression levels of Snail-1 and Twist, which was strongly reversed with TGF-β1 inhibition. These results suggest that the presence of TGF-β1-CD73-Ado feedback loop can promote protumoral characteristics in the CC tumor microenvironment.

Indexed as

Uterine Cervical Neoplasms5'-NucleotidaseAdenosineCell Line, TumorFemaleHumansIntegrin alpha6Transforming Growth Factor beta1Transforming Growth FactorsTumor MicroenvironmentVimentin5'-NucleotidaseAdenosineIntegrin alpha6Transforming Growth Factor beta1Transforming Growth FactorsVimentincancer stem-like (CSC-like) cellsCD73cervical cancerprotumor phenotypeTGF-β 1tumorspheres

Identifiers

PMID36070413
PMCPMC9825969
OpenAlexW4294898296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.